Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26853304 | 0.82 | ALDH1A1 (0.55) | ALDH1A1TSHRTDP1HSD17B10THRB | |
| SCHEMBL9226621 | 0.80 | ALDH1A1 (0.52) | ALDH1A1TSHRTDP1HSD17B10THRB | |
| SCHEMBL14084915 | 0.79 | — | — | |
| SCHEMBL11548091 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TSHRTDP1THRBCHRM2 | |
| SCHEMBL1055057 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TSHRTDP1HSD17B10THRB | |
| SCHEMBL28170047 | 0.78 | ALDH1A1 (0.61) | ALDH1A1TSHRTDP1HSD17B10THRB | |
| SCHEMBL15963 | 0.78 | ALDH1A1 (0.61) | ALDH1A1TSHRTDP1HSD17B10THRB | |
| SCHEMBL6916163 | 0.76 | EPHX1 (0.36) | ALDH1A1CHRM2CHRM4CHRM5CYP2D6 | |
| SCHEMBL28390434 | 0.76 | ALDH1A1 (0.48) | ALDH1A1TSHRTDP1HSD17B10THRB | |
| SCHEMBL8953021 | 0.75 | ALDH1A1 (0.58) | ALDH1A1TSHRTDP1HSD17B10THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0922715-B1 | Stimuli-responsive polymer utilizing keto-enol tautomerization | AGENCY IND SCIENCE TECHN (JP) | 2008-04-02 | — | — | EP | disclosed |
| US-6858694-B2 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY MITI (JP) | 2005-02-22 | — | — | US | disclosed |
| US-6852819-B2 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY MITI (JP) | 2005-02-08 | — | — | US | disclosed |
| US-20040223945-A1 | Stimuti-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | JNC CORPORATION (JP) | 2004-11-11 | — | — | US | disclosed |
| US-20020188084-A1 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | JNC CORPORATION (JP) | 2002-12-12 | — | — | US | disclosed |
| EP-0922715-A2 | Stimuli-responsive polymer utilizing keto-enol tautomerization | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY MITI (JP) | 1999-06-16 | — | — | EP | disclosed |
| US-5892100-A | DEHYDROHALOGENATION BY REACTION OF UNSATURATED ACID HALIDES WITH CARBAMATE IN THE PRESENCE OF HINDERED AMINE | NIPPON PAINT CO., LTD. (JP) | 1999-04-06 | — | — | US | disclosed |
| EP-0827953-A2 | Method for producing N-acyl carbamate | Nippon Paint Co., Ltd. (JP) | 1998-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040223945-A1 | Stimuti-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | CREB1, STIM2, GABRE | ALDH1A1 3954/4885TSHR 2438/4885TDP1 4182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.